paediatrics Brussels 17

First page Table of contents Previous page 937 Next page Last page

Survival

• Patients with localized disease: 5-year EFS: 60-70%

• Patients with metastatic disease: 5-year EFS: 20%

Made with FlippingBook - professional solution for displaying marketing and sales documents online